ag-1296 has been researched along with quinoxalines in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Böhmer, FD; Gazit, A; Heldin, CH; Kovalenko, M; Levitzki, A; Loubtchenkov, M; Rönnstrand, L | 1 |
Carlson, P; Krystal, GW; Litz, J | 1 |
Chen, H; Gazit, A; Hirth, P; Huber, LJ; Levitzki, A; Lipson, KE; McMahon, G; Pang, L; Tsai, JM | 1 |
Banai, S; Fishbein, I; Gazit, A; Gertz, SD; Golomb, G; Huber, R; Lazarovichi, G; Levitzki, A; Pearle, A; Perez, L; Rabinovich, L; Schneider, A; Waltenberger, J; Wolf, Y | 1 |
Aihara, M; Ishiuchi, S; Ohtani, T; Watanabe, T | 1 |
Baell, JB; Botteon, A; Chang, BCH; Danne, J; Ellis, S; Garcia-Bustos, JF; Gasser, RB; Hofmann, A; Jabbar, A; Jiao, Y; Koehler, AV; Le, T; McNamara, N; Nguyen, N; Preston, S; Skinner, C; Ventura, S; Wang, T | 1 |
6 other study(ies) available for ag-1296 and quinoxalines
Article | Year |
---|---|
Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Binding, Competitive; Cell Line; Dimerization; Dogs; Enzyme Inhibitors; Humans; Kinetics; Molecular Sequence Data; Nitriles; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Protein Binding; Quinoxalines; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Swine; Tyrphostins | 1997 |
Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins.
Topics: Apoptosis; Carcinoma, Small Cell; Cell Division; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Lung Neoplasms; Nitriles; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Quinoxalines; Stem Cell Factor; Tumor Cells, Cultured; Tyrphostins | 1997 |
Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Topics: 3T3 Cells; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p27; ErbB Receptors; Mice; Microtubule-Associated Proteins; Nitriles; Phosphorylation; Quinoxalines; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Tumor Suppressor Proteins; Tyrosine; Tyrphostins | 1998 |
PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.
Topics: Angioplasty, Balloon; Animals; Aorta, Abdominal; Carotid Arteries; Cell Division; Cells, Cultured; Endarterectomy, Carotid; Enzyme Inhibitors; Femoral Artery; Humans; Mammary Arteries; Muscle, Smooth, Vascular; Nitriles; Organ Culture Techniques; Phosphorylation; Platelet-Derived Growth Factor; Quinoxalines; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Swine; Tunica Intima; Tyrphostins | 1998 |
Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Glioblastoma; Humans; Imidazoles; In Vitro Techniques; Mice; Mice, Nude; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Quinoxalines; Receptors, AMPA; Receptors, Platelet-Derived Growth Factor; Transplantation, Heterologous; Treatment Outcome; Tyrphostins | 2013 |
Tetrahydroquinoxalines induce a lethal evisceration phenotype in Haemonchus contortus in vitro.
Topics: Animals; Antinematodal Agents; Biological Assay; Drug Discovery; Haemonchus; Inhibitory Concentration 50; Larva; Molting; Phenotype; Quinoxalines; Tyrphostins | 2019 |